VanEck Biotech ETF BBH
257.23 USD -2.21 (-0.85%)
At closeNov 10, 2026, 4:00 PM EST
257.36 +0.13 +0.05%
After hours · Nov 10, 4:00 PM ET
255.88 Day range 258.82
179.25 52-week range 263.74
- YTD
- +35.92%
- 1 year
- +41.03%
News
zacks.com ETFs That You May Consider Amid a Strengthening Biotech Outlook Drug innovation, AI and rising M&A activity are boosting biotech optimism. Discover ETFs offering exposure to the sector.
zacks.com Why Healthcare ETFs Are Hovering Around One-Year Highs Healthcare ETFs are hovering near 52-week highs as earnings prospects improve, clinical breakthroughs advance and GLP-1 demand expands. Explore five ETFs riding the rally.
fool.com Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy? Both of these ETFs look the part, but only one is truly the better buy for investors.
zacks.com Biotech ETF (BBH) Hits New 52-Week High For investors seeking momentum, VanEck Biotech ETF BBH is probably on the radar. The fund just hit a 52-week high and has risen 41.1% from its 52-week low price of $176.30/share.
businesswire.com BBH Capital Partners Private Equity Exits The Granite Group NEW YORK--(BUSINESS WIRE)--BBH Capital Partners Private Equity (BBHCP) today announced the successful exit of its investment in The Granite Group (Granite), a diversified distributor of plumbing and…
fool.com Better Biotechnology ETF: First Trust FBT vs. VanEck BBH The First Trust NYSE Arca Biotechnology Index Fund has outperformed the VanEck Biotech ETF on a one-year basis and over the last five years. The VanEck Biotech ETF offers a lower expense ratio of…
fool.com Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings. Both charge 0.35% annually, but their five-year returns diverged significantly.
fool.com Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? FHLC features a much lower expense ratio of 0.08% compared to 0.35% for BBH. BBH is a concentrated portfolio of just 26 stocks, while FHLC holds around 350 companies.
zacks.com Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate Biotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.
zacks.com Should You Invest in the VanEck Biotech ETF (BBH)? Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December…
fool.com VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper drawdowns.
seekingalpha.com BBH: Biotech's Next Growth Cycle Is Just Getting Started VanEck Biotech ETF (BBH) is a Buy, offering concentrated exposure to leading biotech firms entering a new growth cycle. BBH's top holdings—Amgen, Gilead, and Vertex—drive capital appreciation through…
fool.com In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk.
fool.com State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026? State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio than VanEck Biotech ETF VanEck Biotech ETF focuses exclusively on 25 biotechnology stocks while State Street…
fool.com IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now? IHE pays a meaningfully higher dividend yield than BBH. BBH offers more concentrated exposure with 25 holdings, compared to 56 for IHE.
fool.com Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026? Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to the 25 positions in VanEck Biotech ETF VanEck Biotech ETF has a slightly lower expense ratio of…
zacks.com Should You Invest in the VanEck Biotech ETF (BBH)? Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on December 20, 2011.
fool.com Which is the Better Choice for Healthcare Investors? IYH or BBH? iShares U.S. Healthcare ETF provides broader exposure with 100 holdings compared to the 25 found in VanEck Biotech ETF VanEck Biotech ETF has delivered higher recent total returns but carries…
fool.com BBH vs. XPH: Which Healthcare ETF Is Better for Beginners? State Street SPDR S&P Pharmaceuticals ETF provides exposure to 65 companies compared to the 25 holdings in VanEck Biotech ETF. VanEck Biotech ETF has experienced a deeper maximum drawdown of almost…
fool.com FHLC vs. BBH: Which Healthcare ETF Is the Better Buy? Fidelity MSCI Health Care Index ETF (FHLC) provides broad sector exposure with significantly lower fees than VanEck Biotech ETF (BBH). BBH focuses on just 25 holdings in the biotech space while FHLC…
benzinga.com Judge Hands Natera 30% Ongoing Royalty In MRD Patent Battle Natera rises after a Delaware court grants a 30% ongoing royalty in its MRD patent battle with ArcherDx and Invitae.
benzinga.com Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps Vertex's kidney drug delivers a "clear win" in Phase 3. Clinical success and a 6% premarket jump signal a massive milestone for VRTX.
benzinga.com Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval…
benzinga.com Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug.
benzinga.com New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this…
benzinga.com Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating…
benzinga.com FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits - benzinga.com US Judge Weighs Nationwide Ban On Abortion Pills U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regulatory approval of the abortion pill mifepristone was proper. The judge is…
benzinga.com FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' - benzinga.com 5 Top ETFs With Exposure To Biogen For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA.
benzinga.com 3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a- benzinga.com Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech
- benzinga.com Clinton's Proposal To Combat Drug Price Hikes
- benzinga.com Biotech And Natural Gas ETFs On A Roll
- benzinga.com ETFs to Watch September 9, 2013 (DES, EWJ, FXA)
- benzinga.com Biotech Breakout Highlights Flawed ETF Thinking
- benzinga.com A Look Ahead: This Week's ETFs to Watch
- benzinga.com ETFs to Watch August 6, 2013 (BSV, KOLD, THD)
benzinga.com ETFs to Watch August 1, 2013 (BSV, EWM, XRT) - benzinga.com Seasonal Trends: Three ETFs To Own In August
- benzinga.com Don't Forget About This Small-Cap Health Care ETF
- benzinga.com Interesting Similarities Among 2013's Top-Performing ETFs
benzinga.com S&P Highlights Biotech ETFs - benzinga.com Vertex News Lifts Biotech ETFs
- benzinga.com Under The Hood: An Unheralded Biotech ETF
- benzinga.com Biotech Breakout Boosting ETFs
- benzinga.com Investors Cheating Themselves by Focusing on Largest ETFs
- benzinga.com Argument For Low Volume ETFs Gains Steam
- benzinga.com ETF Winners that Could Keep Their Momentum (EPHE, FBT, XHB)
- benzinga.com Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)